1. Home
  2. TEVA vs HBAN Comparison

TEVA vs HBAN Comparison

Compare TEVA & HBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • HBAN
  • Stock Information
  • Founded
  • TEVA 1901
  • HBAN 1866
  • Country
  • TEVA Israel
  • HBAN United States
  • Employees
  • TEVA N/A
  • HBAN N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • HBAN Major Banks
  • Sector
  • TEVA Health Care
  • HBAN Finance
  • Exchange
  • TEVA Nasdaq
  • HBAN Nasdaq
  • Market Cap
  • TEVA 18.4B
  • HBAN 21.2B
  • IPO Year
  • TEVA N/A
  • HBAN N/A
  • Fundamental
  • Price
  • TEVA $16.94
  • HBAN $15.22
  • Analyst Decision
  • TEVA Strong Buy
  • HBAN Buy
  • Analyst Count
  • TEVA 6
  • HBAN 21
  • Target Price
  • TEVA $24.33
  • HBAN $17.50
  • AVG Volume (30 Days)
  • TEVA 12.6M
  • HBAN 18.5M
  • Earning Date
  • TEVA 05-07-2025
  • HBAN 04-17-2025
  • Dividend Yield
  • TEVA N/A
  • HBAN 4.06%
  • EPS Growth
  • TEVA N/A
  • HBAN 17.13
  • EPS
  • TEVA N/A
  • HBAN 1.30
  • Revenue
  • TEVA $16,616,000,000.00
  • HBAN $7,104,000,000.00
  • Revenue This Year
  • TEVA $6.30
  • HBAN $16.25
  • Revenue Next Year
  • TEVA N/A
  • HBAN $5.04
  • P/E Ratio
  • TEVA N/A
  • HBAN $11.76
  • Revenue Growth
  • TEVA 3.82
  • HBAN 5.17
  • 52 Week Low
  • TEVA $12.47
  • HBAN $11.92
  • 52 Week High
  • TEVA $22.80
  • HBAN $18.45
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 61.30
  • HBAN 61.29
  • Support Level
  • TEVA $14.17
  • HBAN $14.79
  • Resistance Level
  • TEVA $18.30
  • HBAN $15.35
  • Average True Range (ATR)
  • TEVA 0.66
  • HBAN 0.32
  • MACD
  • TEVA 0.37
  • HBAN 0.15
  • Stochastic Oscillator
  • TEVA 71.00
  • HBAN 92.57

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About HBAN Huntington Bancshares Incorporated

Huntington is a regional US bank with around $200 billion in assets (as of 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.

Share on Social Networks: